ArticleScientific reports2025
Volatile dimethyl disulphide emission from Burkholderia cepacia LS-044 suppresses metabolism and budding in caspofungin-resistant Nakaseomyces glabratus NT2.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Some bacteria emit dimethyl disulphide (DMDS), one of the bioactive volatile sulphurous compounds (VSCs) of environmental and ecological significance, yet unexplored in combating drug-resistant yeasts. Here, we show the anti-budding and fungicidal activity of volatile DMDS emitted from Burkholderia cepacia LS-044 on the caspofungin-resistant yeast Nakaseomyces glabratus NT2. We identified a gene encoding L-methionine-γ-lyase (mdeA) catalysing DMDS formation in LS-044 and detected volatile DMDS as one of the VSCs (12% peak area) emitted by LS-044 through solid-phase microextraction followed by gas chromatographic-mass spectrometry. Exposure to volatiles of LS-044 resulted in a significant decline in metabolism (~ 98%), media alkalinity (~ 26%), and viable cell count (52‒95%) of NT2. Confocal microscopy of carboxyfluorescein succinimidyl ester- and calcofluor white stained cells revealed significantly high mean fluorescence in NT2 exposed to the volatiles of LS-044 (~ fivefold) and standard DMDS vapour (1.7-fold), suggesting a significant thickening of the cell wall. The surface area-to-volume ratio decreased significantly in NT2 cells exposed to volatiles of LS-044 and DMDS versus unexposed NT cells (6.5‒10.2 vs. 8.3‒13.2). DMDS exhibited a minimum inhibitory concentration of 0.5% (v/v) on NT2 cells in liquid broth dilution assay, and displayed fractional inhibitory concentration index of 0.95 with commercial antifungal clotrimazole reflecting lack of synergy or antagonism during the present combination therapy. The 26S rRNA gene sequence-based phylogeny revealed a tight phylogenetic association between NT2 and N. glabratus of environmental and clinical origins. Our study provided novel mechanistic insights into DMDS-driven bacterial antagonism on drug-resistant budding yeast N. glabratus NT2 that could be exploited in the ecological engineering and therapeutics of drug-resistant fungal infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.